시장보고서
상품코드
1762443

세계의 응고 시약 시장 규모, 점유율, 동향, 업계 분석 : 검사 유형별, 기술별, 최종 용도별, 지역별 예측(2025-2034년)

Coagulation Reagent Market Size, Share, Trends, & Industry Analysis Report By Test Type (APTT, D-Dimer, Fibrinogen, Prothrombin, Others), By Technology, By End Use, and By Region - Market Forecast, 2025-2034

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 129 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 응고 시약 시장 규모는 2034년까지 82억 9,000만 달러에 달할 전망입니다. 이 조사 리포트는 현재의 시장 역학에 대한 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.

응고 시약은 혈액 응고 과정을 평가하는 데 사용되는 특수 화학 물질로, 출혈 및 혈전성 질환의 진단 검사에 필수적인 구성 요소로 작용합니다. 이러한 시약은 검사실과 의료 전문가가 응고 경로를 정확하게 평가하고, 항응고 요법을 모니터링하고, 혈액학적 기저 질환을 감지하여 효과적인 임상적 의사결정과 환자 관리를 지원할 수 있도록 돕습니다.

응고 시약은 혈액 응고 장애를 감지하고 항응고 요법의 효과를 모니터링하는 데 사용되는 혈액 검사에 필수적인 성분입니다. 이러한 시약은 의료 전문가가 과다 출혈이나 혈전증과 같은 잠재적 위험을 파악하여 적시에 적절한 치료 방침을 결정할 수 있도록 도와줍니다. 응고 시약은 정확한 응고 평가가 적절한 의료 개입을 유도하는 데 중요한 외과수술, 만성질환 모니터링, 응급의료 등에 광범위하게 적용되고 있습니다.

응고 시약 시장 보고서 하이라이트

기술별로는 광학 기술 부문이 우수한 분석 정확도, 신속한 검사 기능, 자동화된 실험실 워크플로우와의 호환성으로 인해 2024년 광학 기술 부문이 큰 시장 점유율을 차지할 것으로 예측됩니다.

최종 용도별로는 수술, 외상 관리, 집중 치료, 만성 응고 장애 모니터링에서 응고 검사가 필수적인 진단 요소로 자리 잡은 종합적인 치료 요건으로 인해 병원 분야가 2024년 시장을 주도했습니다.

북미는 혈액질환 유병률이 높고, 광범위한 진단 검사를 지원할 수 있는 첨단 의료 인프라가 잘 갖추어져 있으며, 2024년 시장 점유율을 독식할 것으로 예측됩니다.

아시아태평양 시장은 예측 기간 중 가장 빠르게 성장할 것으로 예측됩니다. 이는 이 지역의 정부 구상이 증가하고 의료 인프라를 강화하기 위한 투자가 증가하고 있기 때문입니다.

세계의 주요 시장 기업에는 Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Haemonetics Corporation, Sekisui Diagnostics, LLC, Randox Laboratories Ltd, Agappe Diagnostics Ltd 등이 있습니다. 기타 주요 기업에는 Sclavo Vaccines Association, BIO DIAGNOSTICS Ltd, Robonik India Pvt. Ltd. 등이 있습니다.

목차

제1장 서론

제2장 개요

제3장 분석 방법

제4장 세계의 응고 시약 시장 인사이트

  • 시장 스냅숏
  • 응고 시약 시장 역학
    • 촉진요인과 기회
      • 심혈관질환의 이환율 상승에 의해 응고 모니터링의 수요가 높아지고 있다.
      • 세계 인구의 고령화에 의해 응고 검사 솔루션의 필요성이 높아지고 있다.
    • 억제요인과 과제
      • 첨단 응고 검사의 고비용
      • 엄격한 규제 요건
  • PESTLE 분석
  • 응고 시약 시장 동향
  • 밸류체인 분석

제5장 세계의 응고 시약 시장 : 검사 유형별

  • 주요 분석 결과
  • 서론
  • APTT
  • D 다이머
  • 피브리노겐
    • 피브리노겐 : 지역별(2020-2034년)
  • 프로트롬빈
      • 프로트롬빈 : 지역별(2020-2034년)
  • 기타
      • 기타 : 지역별(2020-2034년)

제6장 세계의 응고 시약 시장 : 기술별

  • 주요 분석 결과
  • 서론
  • 기계
  • 전기화학
  • 광학
  • 기타

제7장 세계의 응고 시약 시장 : 최종 용도별

  • 주요 분석 결과
  • 서론
  • 병원
  • 연구기관
  • 진단 센터
  • 기타

제8장 세계의 응고 시약 시장 : 지역별

  • 주요 분석 결과
  • 서론
    • 응고 시약 시장 분석 : 지역별(2020-2034년)
  • 북미
    • 북미 : 검사 유형별(2020-2034년)
    • 북미 : 기술별(2020-2034년)
    • 북미 : 최종 용도별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 검사 유형별(2020-2034년)
    • 유럽 : 기술별(2020-2034년)
    • 유럽 : 최종 용도별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 검사 유형별(2020-2034년)
    • 아시아태평양 : 기술별(2020-2034년)
    • 아시아태평양 : 최종 용도별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 검사 유형별(2020-2034년)
    • 중동 및 아프리카 : 기술별(2020-2034년)
    • 중동 및 아프리카 : 최종 용도별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 검사 유형별, 2020-2034년
    • 라틴아메리카 : 기술별(2020-2034년)
    • 라틴아메리카 : 최종 용도별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 사업 확대·기업 인수 분석
    • 사업 확대
    • 기업 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Sclavo Vaccines Association
  • Randox Laboratories Ltd
  • BIO DIAGNOSTICS Ltd
  • Robonik India Pvt. Ltd.
  • Sekisui Diagnostics, LLC
  • Haemonetics Corporation
  • Agappe Diagnostics Ltd
  • Rayto Life and Analytical Sciences Co., Ltd
  • China Beijing Steellex Scientific Instrument Company
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd.
  • Gesan Production S.r.l.
KSA 25.07.16

The coagulation reagents market size is expected to reach USD 8.29 Billion by 2034, according to a new study by Polaris Market Research. The report "Coagulation Reagent Market Size, Share, Trends, & Industry Analysis Report By Test Type (APTT, D-Dimer, Fibrinogen, Prothrombin, Others), By Technology, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Coagulation reagents are specialized chemical substances used to evaluate blood clotting processes, serving as essential components in diagnostic testing for bleeding and thrombotic disorders. These reagents enable laboratories and healthcare professionals to accurately assess coagulation pathways, monitor anticoagulant therapies, and detect underlying hematologic conditions, thereby supporting effective clinical decision-making and patient management.

Coagulation reagents are essential components in blood testing, used to detect clotting disorders and monitor the effectiveness of anticoagulant therapies. These reagents help healthcare professionals identify potential risks such as excessive bleeding or thrombosis, enabling timely and informed treatment decisions. Coagulation reagents are widely applied in surgical settings, chronic disease monitoring, and emergency care, where accurate coagulation assessment is critical for guiding appropriate medical intervention.

Coagulation Reagent Market Report Highlights

Based on technology, the optical technology segment captured significant market share in 2024, owing to its superior analytical precision, rapid testing capabilities, and compatibility with automated laboratory workflows.

Based on end use, the hospital segment dominated the market in 2024 due to their comprehensive care requirements, where coagulation testing forms an essential diagnostic component for surgical procedures, trauma management, intensive care, and monitoring of chronic coagulation disorders.

North America accounted dominated the market share in 2024 due to the region's high incidence of hematological disorders and its advanced, well-resourced healthcare infrastructure capable of supporting extensive diagnostic testing.

The market in Asia Pacific is projected to experience fastest growth during the forecast period, driven by growing government initiatives and rising investments aimed at strengthening healthcare infrastructure across the region.

A few global key market players include Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Haemonetics Corporation, Sekisui Diagnostics, LLC, Randox Laboratories Ltd, and Agappe Diagnostics Ltd. Other notable players include Sclavo Vaccines Association, BIO DIAGNOSTICS Ltd, Robonik India Pvt. Ltd.

Polaris Market Research has segmented the market report on the basis of test type, technology, end-use, and region:

By Test Type Outlook (Revenue, USD Billion, 2020-2034)

APTT

D-Dimer

Fibrinogen

Prothrombin

Others

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Mechanical

Electrochemical

Optical

Others

By End-Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Research Institutes

Diagnostic Centers

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Coagulation Reagent Market Insights

  • 4.1. Coagulation Reagent Market - Market Snapshot
  • 4.2. Coagulation Reagent Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Cardiovascular Diseases Driving Demand for Coagulation Monitoring
      • 4.2.1.2. Aging Global Population Increasing the Need for Coagulation Testing Solutions
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Advanced Coagulation Testing
      • 4.2.2.2. Stringent Regulatory Requirements
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Coagulation Reagent Market Trends
  • 4.6. Value Chain Analysis

5. Global Coagulation Reagent Market, by Test Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
  • 5.3. APTT
    • 5.3.1. Global Coagulation Reagent Market, by APTT, by Region, 2020-2034 (USD Billion)
  • 5.4. D-Dimer
      • 5.4.1.1. Global Coagulation Reagent Market, by D-Dimer, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Global Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
  • 5.5. Fibrinogen
    • 5.5.1. Global Coagulation Reagent Market, by Fibrinogen, by Region, 2020-2034 (USD Billion)
  • 5.6. Prothrombin
      • 5.6.1.1. Global Coagulation Reagent Market, by Prothrombin, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
      • 5.7.1.1. Global Coagulation Reagent Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Coagulation Reagent Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
  • 6.3. Mechanical
    • 6.3.1. Global Coagulation Reagent Market, by Mechanical, by Region, 2020-2034 (USD Billion)
  • 6.4. Electrochemical
    • 6.4.1. Global Coagulation Reagent Market, by Electrochemical, by Region, 2020-2034 (USD Billion)
  • 6.5. Optical
    • 6.5.1. Global Coagulation Reagent Market, by Optical, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Coagulation Reagent Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Coagulation Reagent Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Coagulation Reagent Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Research Institutes
    • 7.4.1. Global Coagulation Reagent Market, by Research Institutes, by Region, 2020-2034 (USD Billion)
  • 7.5. Diagnostic Centers
    • 7.5.1. Global Coagulation Reagent Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Coagulation Reagent Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Coagulation Reagent Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Coagulation Reagent Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Coagulation Reagent Market - North America
    • 8.3.1. North America: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.3. North America: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.3.4. Coagulation Reagent Market - U.S.
      • 8.3.4.1. U.S.: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.3.5. Coagulation Reagent Market - Canada
      • 8.3.5.1. Canada: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
  • 8.4. Coagulation Reagent Market - Europe
    • 8.4.1. Europe: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.4. Coagulation Reagent Market - UK
      • 8.4.4.1. UK: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.5. Coagulation Reagent Market - France
      • 8.4.5.1. France: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.6. Coagulation Reagent Market - Germany
      • 8.4.6.1. Germany: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.7. Coagulation Reagent Market - Italy
      • 8.4.7.1. Italy: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.8. Coagulation Reagent Market - Spain
      • 8.4.8.1. Spain: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.9. Coagulation Reagent Market - Netherlands
      • 8.4.9.1. Netherlands: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.10. Coagulation Reagent Market - Russia
      • 8.4.10.1. Russia: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.4.11. Coagulation Reagent Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
  • 8.5. Coagulation Reagent Market - Asia Pacific
    • 8.5.1. Asia Pacific: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.4. Coagulation Reagent Market - China
      • 8.5.4.1. China: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.5. Coagulation Reagent Market - India
      • 8.5.5.1. India: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.6. Coagulation Reagent Market - Malaysia
      • 8.5.6.1. Malaysia: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.7. Coagulation Reagent Market - Japan
      • 8.5.7.1. Japan: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.8. Coagulation Reagent Market - Indonesia
      • 8.5.8.1. Indonesia: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.9. Coagulation Reagent Market - South Korea
      • 8.5.9.1. South Korea: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.10. Coagulation Reagent Market - Australia
      • 8.5.10.1. Australia: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.5.11. Coagulation Reagent Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
  • 8.6. Coagulation Reagent Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.4. Coagulation Reagent Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.5. Coagulation Reagent Market - UAE
      • 8.6.5.1. UAE: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.6. Coagulation Reagent Market - Israel
      • 8.6.6.1. Israel: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.7. Coagulation Reagent Market - South Africa
      • 8.6.7.1. South Africa: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.6.8. Coagulation Reagent Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
  • 8.7. Coagulation Reagent Market - Latin America
    • 8.7.1. Latin America: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.7.4. Coagulation Reagent Market - Mexico
      • 8.7.4.1. Mexico: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.7.5. Coagulation Reagent Market - Brazil
      • 8.7.5.1. Brazil: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.7.6. Coagulation Reagent Market - Argentina
      • 8.7.6.1. Argentina: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)
    • 8.7.7. Coagulation Reagent Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Coagulation Reagent Market, by Test Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Coagulation Reagent Market, by Technology, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Coagulation Reagent Market, by End-Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Sclavo Vaccines Association
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Randox Laboratories Ltd
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BIO DIAGNOSTICS Ltd
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Robonik India Pvt. Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Sekisui Diagnostics, LLC
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Haemonetics Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Agappe Diagnostics Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Rayto Life and Analytical Sciences Co., Ltd
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. China Beijing Steellex Scientific Instrument Company
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Siemens Healthineers AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. F. Hoffmann-La Roche Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Gesan Production S.r.l.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제